Reference Source

Cybermed Industries · 66-41 · CANADA

For Cybermed Industries · 66-41 · CANADA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CANADA; product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is 204-1010 View St. , Victoria, BC CANADA, verified against its source on 2026-09-16.

Firm
Cybermed Industries verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CANADA verified
Address
204-1010 View St. , Victoria, BC CANADA verified
Date published
09/30/2009 verified
Product code
54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
FDA notes
5/26/2005 Power Enlarge Patch is offered for sale on this firms internet site at www.enlargepatch.com. This product is promoted as a transdermal patch that infuses its ingrediants directly into the bloodstream, bypassing the digestive system. Based on its intended uses, Power Enlarge Patch is a drug. As labeled and formulated, this drug is not generally recognized as safe and effectived bt experts and is a new drug marketed without and approved new drug application. Furthermore, because this product is a transdermal drug, the method of administration or application suggested in the labeling causes it to be a new drug. See 21 CFR 310.2(h)(5) Per CDER the appropriate charge is 505 (a). | 5/26/2005 each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Cybermed Industries Date Published : 09/30/2009 204-1010 View St. , Victoria, BC CANADA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 09/30/2009 Notes: 5/26/2005 Power Enlarge Patch is offered for sale on this firms internet site at www.enlargepatch.com. This product is promoted as a transdermal patch that infuses its ingrediants directly into the bloodstream, bypassing the digestive system. Based on its intended uses, Power Enlarge Patch is a drug. As labeled and formulated, this drug is not generally recognized as safe and effectived bt experts and is a new drug marketed without and approved new drug application. Furthermore, because this product is a transdermal drug, the method of administration or application suggested in the labeling causes it to be a new drug. See 21 CFR 310.2(h)(5) Per CDER the appropriate charge is 505 (a). 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/30/2009 Notes: 5/26/2005

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.